Trial Profile
The effects of metabolic parameters of aripiprazole in patients with schizophrenia.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 17 Jun 2009 Planned end date changed from 1 Sep 2009 to 1 Oct 2009 as reported by ClinicalTrials.gov.
- 14 Jul 2008 Status changed from in progress to recruiting as reported by ClinicalTrials.gov.
- 28 Dec 2007 New trial record.